Recommendations for the prevention and treatment of haemolytic disease of the foetus and newborn.
作者信息
Bennardello Francesco, Coluzzi Serelina, Curciarello Giuseppe, Todros Tullia, Villa Stefania
机构信息
Immunohaematology and Transfusion Medicine Centre, Provincial Health Authority n. 7, Ragusa, Italy.
Immunohaematology and Transfusion Medicine Centre, "La Sapienza" University, Rome, Italy.
出版信息
Blood Transfus. 2015 Jan;13(1):109-34. doi: 10.2450/2014.0119-14.
Abstract
摘要
相似文献
1
Recommendations for the prevention and treatment of haemolytic disease of the foetus and newborn.胎儿和新生儿溶血病的预防与治疗建议。
Blood Transfus. 2015 Jan;13(1):109-34. doi: 10.2450/2014.0119-14.
2
Rh haemolytic disease of the newborn: the role of the laboratory.
Med Lab Sci. 1982 Jul;39(3):297-303.
3
[Haemolytic disease of the newborn (fetus) (author's transl)].新生儿（胎儿）溶血病（作者译）
Immun Infekt. 1976 Dec;4(6):249-60.
4
The prevention of haemolytic disease of the newborn.
Ir J Med Sci. 1967 Jun;6(498):276-80.
5
Amniocentesis in erythroblastosis fetalis.
Md State Med J. 1966 Sep;15(9):115-7.
6
[Work of the maternity hospital No. 23 specializing in the prevention and treatment of hemolytic disease of newborn].
Akush Ginekol (Mosk). 1974 Nov(11):50-4.
7
[ABO incompatibility and newborn haemolytic disease: two cases with major erythroblastosis].[ABO血型不合与新生儿溶血病：两例重度成红细胞增多症病例]
Ann Biol Clin (Paris). 2004 May-Jun;62(3):344-8.
8
Rhesus haemolytic disease; an approach to prevention.
Nurs Times. 1965 Sep 17;61(38):1267-9.
9
Prevention of haemolytic disease of the newborn by the administration of anti-D to the mother.
Ger Med Mon. 1969 Feb;14(2):58-62.
10
Prevention of rhesus haemolytic disease of the fetus and newborn.
Lancet. 2009 Mar 28;373(9669):1082. doi: 10.1016/S0140-6736(09)60651-6.
引用本文的文献
1
HPLC and flow cytometry combined approach for HbF analysis in fetomaternal haemorrhage evaluation.高效液相色谱法与流式细胞术联合用于胎儿-母体出血评估中血红蛋白F分析的方法
Pract Lab Med. 2024 May 16;40:e00401. doi: 10.1016/j.plabm.2024.e00401. eCollection 2024 May.
2
Misclassification of RhD variants among pregnant women: a systematic review.孕妇 RhD 变异型的错误分类：系统评价。
J Med Life. 2023 Jul;16(7):981-989. doi: 10.25122/jml-2023-0004.
3
Early Hyporegenerative Anemia Complicating Hemolytic Disease of the Newborn Secondary to Rhesus Alloimmunization.由恒河猴同种免疫引起的新生儿溶血病并发早期再生低下性贫血
Cureus. 2021 Nov 15;13(11):e19603. doi: 10.7759/cureus.19603. eCollection 2021 Nov.
4
Hemolytic disease of the fetus and newborn due to Rh(D) incompatibility: A preventable disease that still produces significant morbidity and mortality in children.由 Rh(D) 不相容引起的胎儿和新生儿溶血病：一种可预防的疾病，但仍会导致儿童出现严重的发病率和死亡率。
PLoS One. 2020 Jul 20;15(7):e0235807. doi: 10.1371/journal.pone.0235807. eCollection 2020.
5
Recombinant anti-D for prevention of maternal-foetal Rh(D) alloimmunization: a randomized multi-centre clinical trial.重组抗D预防母婴Rh（D）血型不合免疫：一项随机多中心临床试验。
Obstet Gynecol Sci. 2020 May;63(3):315-322. doi: 10.5468/ogs.2020.63.3.315. Epub 2020 Apr 21.
6
The contribution of iron deficiency to the risk of peripartum transfusion: a retrospective case control study.缺铁对围产期输血风险的影响：一项回顾性病例对照研究。
BMC Pregnancy Childbirth. 2020 Apr 6;20(1):196. doi: 10.1186/s12884-020-02886-z.
7
Hyporegenerative anemia and other complications of rhesus hemolytic disease: to treat or not to treat is the question.恒河猴溶血性疾病的再生障碍性贫血及其他并发症：治疗与否是个问题。
Pan Afr Med J. 2019 Mar 14;32:120. doi: 10.11604/pamj.2019.32.120.17757. eCollection 2019.
8
Frequency of Red Cell Alloantibodies in Pregnant Females of Navsari District: An Experience that Favours Inclusion of Screening for Irregular Erythrocyte Antibody in Routine Antenatal Testing Profile.纳夫萨里地区孕妇红细胞同种抗体的频率：支持在常规产前检查项目中纳入不规则红细胞抗体筛查的经验。
J Obstet Gynaecol India. 2018 Aug;68(4):300-305. doi: 10.1007/s13224-017-0984-5. Epub 2017 Mar 29.
9
Anti-D Antibodies in Pregnant D Variant Antigen Carriers Initially Typed as RhD.最初血型鉴定为RhD的妊娠D变异抗原携带者中的抗-D抗体
Transfus Med Hemother. 2016 Nov;43(6):419-424. doi: 10.1159/000446816. Epub 2016 Oct 14.
本文引用的文献
1
BCSH guideline for the use of anti-D immunoglobulin for the prevention of haemolytic disease of the fetus and newborn.英国血液学标准委员会关于使用抗-D免疫球蛋白预防胎儿和新生儿溶血病的指南。
Transfus Med. 2014 Feb;24(1):8-20. doi: 10.1111/tme.12091.
2
Survey on the prevention and incidence of haemolytic disease of the newborn in Italy.意大利新生儿溶血病的预防与发病率调查。
Blood Transfus. 2013 Oct;11(4):518-27. doi: 10.2450/2013.0179-12. Epub 2013 Jun 14.
3
Consequences of being Rhesus D immunized during pregnancy and how to optimize new prevention strategies.妊娠期间 RhD 免疫的后果，以及如何优化新的预防策略。
Acta Obstet Gynecol Scand. 2013 Sep;92(9):1079-85. doi: 10.1111/aogs.12193. Epub 2013 Jul 5.
4
Anti-D administration after spontaneous miscarriage for preventing Rhesus alloimmunisation.自然流产后给予抗-D预防恒河猴同种免疫。
Cochrane Database Syst Rev. 2013 Mar 28;2013(3):CD009617. doi: 10.1002/14651858.CD009617.pub2.
5
Anti-D administration in pregnancy for preventing Rhesus alloimmunisation.孕期注射抗-D预防恒河猴血型同种免疫。
Cochrane Database Syst Rev. 2013 Feb 28(2):CD000020. doi: 10.1002/14651858.CD000020.pub2.
6
Intramuscular versus intravenous anti-D for preventing Rhesus alloimmunization during pregnancy.孕期肌内注射与静脉注射抗D预防恒河猴同种免疫反应的比较。
Cochrane Database Syst Rev. 2013 Jan 31;2013(1):CD007885. doi: 10.1002/14651858.CD007885.pub2.
7
Variants of RhD--current testing and clinical consequences.RhD 血型变体——当前的检测及临床意义。
Br J Haematol. 2013 May;161(4):461-70. doi: 10.1111/bjh.12275. Epub 2013 Feb 25.
8
A simple approach to confirm the presence of anti-D in sera with presumed anti-D+C specificity.一种用于确认具有假定抗-D+C特异性的血清中抗-D存在的简单方法。
Blood Transfus. 2013 Jul;11(3):449-51. doi: 10.2450/2012.0192-12. Epub 2013 Jan 23.
9
Guidelines for pre-transfusion compatibility procedures in blood transfusion laboratories. British Committee for Standards in Haematology.输血实验室输血前相容性检测程序指南。英国血液学标准委员会。
Transfus Med. 2013 Feb;23(1):3-35. doi: 10.1111/j.1365-3148.2012.01199.x. Epub 2012 Dec 6.
10
Therapeutic management of fetal anemia: review of standard practice and alternative treatment options.胎儿贫血的治疗管理：标准实践与替代治疗方案的回顾。
J Perinat Med. 2013 Jan;41(1):71-82. doi: 10.1515/jpm-2012-0093.
Zotero 插件